Future Perspectives on the Treatment of Achondroplasia
2020-12-22Research
Among many rare skeletal disorders, achondroplasia is one of the best known and understood. Yet, its management and treatment are still a major challenge for research centers.
First children with achondroplasia receive Recifercept
2020-12-16Research
Pfizer released a Press Statement of the first children with achondroplasia receiving Recifercept, initiating the Phase 2 clinical trial
Phase 2 Clinical trial with Recifercept starts in December 2020
2020-11-24Research
The Phase 2 Study Of Safety, Tolerability And Effectiveness Of Reciferecept In Children With Achondroplasia is now live in Clinicaltrial.gov
Updates on BioMarin clinical development programme
2020-10-26Research
BioMarin shared an update on the 111-209: Phase 2 Study for Children at Risk of Requiring Cervicomedullary Decompression Surgery and the publication of Phase 3 clinical study.
Pfizer starts phase 1 study with Recifercept
2020-10-07Research
Phase 1 Study to Evaluate The Pharmacokinetics, Safety, And Tolerability Of Single Or Multiple Subcutaneous Doses of Recifercept is now active.
Vosoritide phase 3 clinical trial data have been published
2020-09-30Research
Results from the phase 3 clinical trial for vosoritide, that involved children with achondroplasia with ages between 5 to 18 years have been published.
